Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years [Phase 3]
Phase 3 trial to evaluate immunogenicity and safety of MG1111 (BARYCELA Inj.) given as two doses in healthy children aged 12 months to 12 ye…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Second Dose of Varicella Vaccine in Healthy Children [Phase 3]
This document reports a Phase 3 trial evaluating a second dose of Varicella vaccine in healthy children; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial [Phase 3]
A Phase 3 bridging trial to evaluate the immunogenicity and safety of a live varicella vaccine in healthy Vietnamese children aged 1–12 year…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years [Phase 3]
Phase 3 trial update for SkyVaricella (NBP608) in healthy children shows lower potencies. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age [Phase 3]
This Phase 3 clinical trial evaluates the immune response and safety of an investigational combined measles, mumps, rubella and varicella va…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-01-22FDA Approved: ACYCLOVIR — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for acyclovir from Apotex Corp., granting approval for their generic acyclovir product. This act…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program
A completed clinical trial assessing seroprevalence and vaccination rates for hepatitis B and varicella in medical students under an immuniz…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above [Phase 2]
Phase II clinical trial update for a lyophilized herpes zoster mRNA vaccine in adults aged 40 and above; the trial is currently not recruiti…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age [Phase 3]
A Phase 3 trial evaluating the immune response and safety of a second dose of an investigational varicella (chickenpox) vaccine in healthy c…
-
FDA approval · 2025-11-12FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) filed by GlaxoSmithKline LLC under NDA020487. The action up…
-
EMA approval · 2025-09-25EMA Authorised: ProQuad (virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella) — Merck Sharp & Dohme B.V.
EMA has authorized ProQuad, a live attenuated vaccine that protects against varicella (chickenpox), measles, mumps and rubella in the Europe…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]
Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vacc…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years [Phase 1]
A Phase 1 trial to evaluate the EuHZV vaccine in healthy adults aged 50 to 69 years is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Study on Booster Immunization With Varicella Vaccine at Different Intervals [Phase 4]
A Phase 4 study evaluating booster immunization with the varicella vaccine at different intervals has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion) [Phase 4]
A Phase 4 study completed evaluating simultaneous administration of varicella attenuated live vaccine and trivalent inactivated influenza va…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age [Phase 2]
Phase 2 trial evaluating immune response and safety of multiple doses of an investigational varicella (chickenpox) vaccine compared with a m…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: ACTIVATE in Public Housing [NA]
A completed clinical trial (ACTIVATE) in public housing studying interventions related to pneumonia, influenza, varicella, meningitis, COVID…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines [Phase 3]
A Phase 3 study evaluating the immunogenicity and safety of a live varicella vaccine in healthy children aged 12-15 months in the Philippine…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Correlation of Protection Against Varicella in an Exploratory Study
This document updates a clinical trial exploring the correlation of protection against varicella in an exploratory study; the trial is not y…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine [Phase 4]
An ongoing Phase 4 study is evaluating immunity persistence after a booster dose of a live attenuated varicella vaccine. The trial is sponso…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: An Immunity Persistence Study of Live Attenuated Varicella Vaccine [Phase 4]
A Phase 4 immunity persistence study of a live attenuated varicella vaccine is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of a live attenuated varicella vaccine in children aged 1-12 years has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years [Phase 3]
Phase III trial evaluating the immunogenicity and safety of a lyophilized live-attenuated varicella vaccine in healthy subjects aged 13 to 5…